期刊文献+

冠状动脉介入治疗缺血性心肌病顽固性心力衰竭 被引量:12

Percutaneous coronary intervention in patients with refractory heart failure secondary to ischemic cardiomyopathy
原文传递
导出
摘要 目的评价经皮冠状动脉介入治疗(PCI)对缺血性心肌病顽固性心力衰竭的安全性及有效性。方法经冠状动脉造影证实为缺血性心肌病的顽固性心力衰竭患者,在进行了规范化药物治疗后行PCI治疗,至少完成部分血运重建。对比PCI术前及术后3个月超声心动图检查左室射血分数(LVEF)、左室舒张末内径(LVEDD)、X线心胸比例、NY-HA心功能分级及6 min步行距离,以评价PCI对患者心功能的影响。结果 26例缺血性心肌病顽固性心力衰竭患者均经PCI完成血运重建。与术前相比,患者临床症状明显减轻,NYHA心功能分级改善2级,6 min步行距离明显增加[(125±36)m vs(385±68)m,P<0.01],LVEF明显提高[(32.5±8.8)%vs(49.4±8.6)%,P<0.01],LVEDD明显缩小[(64±18)mm vs(61±16)mm,P<0.05],X线心胸比例明显缩小(0.69±0.15 vs 0.60±0.13,P<0.05)。未出现严重并发症。结论 PCI可以明显改善缺血性心肌病顽固性心力衰竭患者的心功能,提高其生活质量,近期效果好。PCI时应选择合理的血运重建策略,掌握恰当的操作方法,以确保手术安全有效。 Objective To evaluate the efficacy and safety of percutaneous coronary intervention(PCI)in patients with refractory heart failure(RHF)secondary to ischemic cardiomyopathy(ICM).Methods For patients sufferring from ischemic cardiomyopathy confirmed by coronary artery angiography with refractory heart failure,PCI were carried out after standard drug therapy,completed at least part of revascularization.To evaluate the influence of PCI on cardiac function,left ventricular ejection fraction(LVEF),left ventricular end-diastolic diameter(LVEDD),X-ray cardiothoracic ratio,NYHA classification heart function and 6 min walking distance were contrasted PCI preoperative and postoperative three months.Results Reascularization by PCI were successful in all the 26 cases of ICM with RHF.Compared with preoperation,all the patients relieved obviously,the patients' NYHA classification cardiae function were improved by 2 levels,6 min walking distance increased obviously from(125±36)m to(385±68)m(P0.01),LVEF increased from(32.5±8.8)% to(49.4±8.6)%(P0.01),LVEDD decreased obviously from(64±18)mm to(61±16)mm(P0.05),X-ray cardiothoracic ratio decreased from 0.69±0.15 to 0.60±0.13(P0.05).And there was no svere complication.Conclusion PCI can significantly improve cardiae function and quality of life in patients with refractory heart failure secondary to ischemic cardiomyopathy.The short-term effect is good.To ensure safety and effectiveness,the reasonable reascularization strategy should be chosen and the right operation method should be grasped in the process.
机构地区 解放军
出处 《临床医学》 CAS 2013年第2期17-19,共3页 Clinical Medicine
关键词 经皮冠状动脉介入治疗 缺血性心肌病 心力衰竭 心功能 Percutaneous coronary intervention Ischemic cardiomyopathy Heart failure Cardiac function
  • 相关文献

参考文献9

  • 1Tenenbaum A, Fisman EZ, Motro M. Toward a redefinition of ische-mic cardiomyopathy : is it an indivisible entity [J] . J Am Coll Cardial,2002,40(l):205 -206.
  • 2无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3674
  • 3高润霖,刘冰.经皮冠状动脉介入治疗指南[J].中华心血管病杂志,2002,30(12):707-718. 被引量:334
  • 4Kalra DK, Zoghbi WA. Myocardial hibernation in coronary arterydiease[ J] . Curr Atheroscler Ren,2002 ,4(2) : 149.
  • 5Bolognese L, Neskovic AN, Parodi G, et al. Left ventricular remode-ling after primary coronary angioplasty patterns of left ventricular dila-tion and long-term prognostic implations [ J ]. Circulation, 2002, 106(18):2351 -2357.
  • 6Hoffman SN, TenBook JA, Wolf MP, et al. A meta-analysis of ran-domized controlled trials comparing coronary artery bypass graft withpercutaneous transluminal coronary angioplasty : one to eight year out-comes[ J]. J Am Coll Cardio,2003,41 (1) :129 - 135.
  • 7Kapur A,Bartolini D,Finlay MC,et al. The bypass angioplasty revas-cularization in type 1 and type 2 diabetes study .. 5-year follow up of re-vascularization with percutaneous coronary intervention versus coronaryartery bypass grafting in diabetc patients with multivessel disease [J].JCardiovasc Med( Hagerstown) ,2010,11(1) :26 -33.
  • 8姜云发,范卫泽,谷新顺,郝国贞,傅向华.PCI治疗慢性闭塞病变伴侧支循环的缺血性顽固性心力衰竭[J].河北医科大学学报,2007,28(2):89-91. 被引量:4
  • 9韩雅玲,臧红云,王冬梅,荆全民,王守力,王祖禄.冠状动脉介入治疗联合心脏再同步化治疗缺血性心肌病顽固性心力衰竭[J].中华心血管病杂志,2005,33(1):17-21. 被引量:30

二级参考文献56

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 2于全俊 见:陈在嘉 高润霖 主编.缺血性心肌病的治疗与预后[A].见:陈在嘉,高润霖,主编.冠心病.第2版[C].北京:人民卫生出版社,2003.1136-1139.
  • 3Rodkey SM, Ratliff NB, Young JB. Cardiomyopathy and myocardial failure. In: Topol EJ, ed. Coprehensive cardiovarscular medicine. Philadelphia: Lippincott-Raven Publishers,1998.2599-2601.
  • 4Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices:summary article. Circulation,2002,15:2145-2161.
  • 5Smith SC Jr, Dove JT, Jacobs AK, et al.ACC/AHA guidelines of percutaneous coronary interventions revision of the 1993 PTCA guidelines: a report of the American college of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). Circulation,2001,103:3019-3041.
  • 6Senior R, Kaul S, Lahiri A. Myocardial viability predicts regression of remodeling following revascularisation compared to medical therapy in ischemic cardiomypathy. Eur Heart J,2000,Suppl:21.
  • 7Abraham WT. Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure:the Multicenter Insync Randomized Clinical Evaluation(MIRACLE). J Card Fail,2000, 6:369-380.
  • 8Lau CP, Yu CM, Chau E, et al. Reversal of left ventricular remodeling by synchronous biventricular pacing in heart failure. PACE,2000,23:1722-1725.
  • 9Nelson GS, Berger RD, Fetics BJ, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-brunch block .Circulation,2000,102:3053-3059.
  • 10Yu CM, Chau E, Sanderson JE. Tissue doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation,2002,109:438-445.

共引文献4031

同被引文献69

引证文献12

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部